Clario and CellCarta Collaborate to Improve Histopathology Services in Clinical Trials
Clario, a healthcare research technology company specializing in clinical trial endpoint solutions, has entered into a strategic partnership with CellCarta, a leader in integrated sample management and laboratory services. This collaboration aims to improve clinical trial sample handling and digitization within Clario’s web-based platform for histopathology studies.
The partnership between Clario and CellCarta brings together innovative endpoint technologies and sample management expertise to offer a comprehensive solution for imaging and histopathology in clinical trials. This strategic alliance will have a significant impact on the handling of tissue and biopsy samples, ensuring seamless operations and increased accessibility for pathology-related trials across multiple therapeutic areas, including oncology, hepatology, and gastroenterology.
Key highlights of the partnership:
1. Streamlined Sample Handling: The collaboration will streamline the logistics of tissue and biopsy samples, making it easier for clinical trial sites to submit pathology data in various formats, including fixed tissue, tissue blocks, glass slides, or whole slide images. This flexibility will expand the number of sites that can participate in pathology-related trials, removing barriers related to local histopathology support staff or equipment availability.
2. Consistency and Quality: CellCarta’s detailed standard operating procedures (SOPs) will ensure that samples are processed and digitized consistently across their multiple geographic locations. This approach minimizes variability in centralized assessments and reduces potential quality issues.
3. Efficiency and Acceleration: The partnership offers several features to enhance efficiency, including the automated and secure transfer of digitized pathology images from the CellCarta portal to Clario’s web-based 21 CFR Part 11 compliant platform. This eliminates delays related to manual data transfer and enables accelerated centralized assessments.
Dr. Joyce Suhy, Executive Vice President, Medical Imaging and Specialty Solutions at Clario, expressed enthusiasm about the collaboration, emphasizing that it combines Clario’s scientific expertise and clinical trial endpoint solutions with CellCarta’s sample processing and management capabilities. This partnership enhances Clario’s ability to support histopathology studies, providing customers with full visibility of biopsy sample logistics and expediting the delivery of centralized assessments for eligibility and efficacy endpoints.
CellCarta’s clinical trial sample management services encompass kit provisioning, sample accessioning, processing, digitization, and quality control. They offer extensive histopathology testing and imaging services. The secure transfer of digitized pathology images between platforms ensures a seamless and efficient workflow. By conducting whole slide image reviews within Clario’s platform, the need for third-party software is eliminated, further expediting assessments.
Clario’s technology is used in 70% of clinical trials (between 2019 and 2020). Clario is a global leader in centralized medical imaging services for clinical trials. Their SMART technology suite offers a secure and integrated system for processing medical images. This suite covers electronic image transfer, independent analysis, and data transfer, ensuring streamlined and efficient handling of medical imaging data in trials. Additionally, Clario’s trial enablement solutions are designed to seamlessly collect, integrate, and analyze data throughout the trial journey. This includes Electronic Data Capture (EDC), Clinical Trial Management (CTMS), Clinical Adjudication, and Eligibility solutions. They are also a leader in AI analysis tools for clinical trial support.
The collaboration between Clario and CellCarta harnesses each companies respective strengths to improve their histopathology offering in support of clinical trials. It offers customers comprehensive, single-vendor solutions that go beyond industry standards, enabling seamless integration of imaging, pathology, and other clinical trial endpoints within a single platform.